Weinstein, Rachel B. http://orcid.org/0000-0002-0023-9578
Ryan, Patrick B.
Berlin, Jesse A.
Schuemie, Martijn J.
Swerdel, Joel
Fife, Daniel
Article History
First Online: 4 June 2020
Compliance with Ethical Standards
:
: No sources of funding were used to conduct this study or prepare this article. Johnson & Johnson will be the sponsor of Open Access, if applicable.
: This study is based on data from the CPRD obtained under license from the UK Medicines and Healthcare Products Regulatory Agency.
: The CPRD has been transformed into the OMOP CDM, version 5. The complete specification for OMOP CDM, version 5, is available at ExternalRef removed. The extract, transform, load (ETL) specification for transforming the CPRD into the OMOP CDM is available at ExternalRef removed. The analysis source code for this study was posted on the Observational Health Data Sciences and Informatics (OHDSI) website Repository of OHDSI Collaborative Research Protocols (ExternalRef removed).
: Jesse A. Berlin, Daniel Fife, Patrick B. Ryan, Martijn J. Schuemie, Joel Swerdel, and Rachel B. Weinstein were full-time employees of Johnson & Johnson, or a subsidiary, at the time the study was conducted. Johnson & Johnson manufactures several medications that contain paracetamol or ibuprofen. Jesse A. Berlin, Daniel Fife, Patrick B. Ryan, Martijn J. Schuemie, Joel Swerdel, and Rachel B. Weinstein own stock, stock options, and pension rights from the company.
: The pre-specified protocol for this study is available at ExternalRef removed and was approved by the data provider’s Independent Scientific Advisory Committee (Protocol 18_100R).